Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Tuberculosis Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Tuberculosis Therapeuticsmarket, defines the market attractiveness level of Tuberculosis Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Tuberculosis Therapeutics industry, describes the types of Tuberculosis Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tuberculosis Therapeutics market and the development prospects and opportunities of Tuberculosis Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tuberculosis Therapeutics market in Chapter 13.
By Player:
Sigma Pharmaceutical Pty
Sanofi -Aventis
Novartis AG
Bayer Health Care
Aventis Pharmaceuticals
Hoffmann-La Roche
Versapharma Incorporated
By Type:
Isoniazid
Rifampin
Pyrazinamide
Hydrazine Derivatives
Miscellaneous Anti-Tubercular Drugs
Ethambutol
By End-User:
Ambulatory Surgical Centers
Hospital Pharmacies
Individual Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Tuberculosis Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Tuberculosis Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Tuberculosis Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Tuberculosis Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Tuberculosis Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Tuberculosis Therapeutics Consumption (2017-2022)
-
7.2 United States Tuberculosis Therapeutics Consumption (2017-2022)
-
7.3 Europe Tuberculosis Therapeutics Consumption (2017-2022)
-
7.4 China Tuberculosis Therapeutics Consumption (2017-2022)
-
7.5 Japan Tuberculosis Therapeutics Consumption (2017-2022)
-
7.6 India Tuberculosis Therapeutics Consumption (2017-2022)
-
7.7 South Korea Tuberculosis Therapeutics Consumption (2017-2022)
8 Region and Country-wise Tuberculosis Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Tuberculosis Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Tuberculosis Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Tuberculosis Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Tuberculosis Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Tuberculosis Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Tuberculosis Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Tuberculosis Therapeutics Consumption Forecast (2022-2028)
9 Global Tuberculosis Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Tuberculosis Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Isoniazid Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Rifampin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Pyrazinamide Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Hydrazine Derivatives Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Miscellaneous Anti-Tubercular Drugs Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Ethambutol Consumption and Growth Rate (2017-2022)
-
9.2 Global Tuberculosis Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Individual Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Tuberculosis Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Tuberculosis Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Isoniazid Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Rifampin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Pyrazinamide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Hydrazine Derivatives Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Miscellaneous Anti-Tubercular Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Ethambutol Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Tuberculosis Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Individual Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Tuberculosis Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Tuberculosis Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Tuberculosis Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Tuberculosis Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Tuberculosis Therapeutics Market Competitive Analysis
-
14.1 Sigma Pharmaceutical Pty
-
14.1.1 Sigma Pharmaceutical Pty Company Details
-
14.1.2 Sigma Pharmaceutical Pty Tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sigma Pharmaceutical Pty Tuberculosis Therapeutics Product and Service
-
14.2 Sanofi -Aventis
-
14.2.1 Sanofi -Aventis Company Details
-
14.2.2 Sanofi -Aventis Tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanofi -Aventis Tuberculosis Therapeutics Product and Service
-
14.3 Novartis AG
-
14.3.1 Novartis AG Company Details
-
14.3.2 Novartis AG Tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis AG Tuberculosis Therapeutics Product and Service
-
14.4 Bayer Health Care
-
14.4.1 Bayer Health Care Company Details
-
14.4.2 Bayer Health Care Tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bayer Health Care Tuberculosis Therapeutics Product and Service
-
14.5 Aventis Pharmaceuticals
-
14.5.1 Aventis Pharmaceuticals Company Details
-
14.5.2 Aventis Pharmaceuticals Tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Aventis Pharmaceuticals Tuberculosis Therapeutics Product and Service
-
14.6 Hoffmann-La Roche
-
14.6.1 Hoffmann-La Roche Company Details
-
14.6.2 Hoffmann-La Roche Tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Hoffmann-La Roche Tuberculosis Therapeutics Product and Service
-
14.7 Versapharma Incorporated
-
14.7.1 Versapharma Incorporated Company Details
-
14.7.2 Versapharma Incorporated Tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Versapharma Incorporated Tuberculosis Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Tuberculosis Therapeutics
-
Figure Tuberculosis Therapeutics Picture
-
Table Global Tuberculosis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tuberculosis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tuberculosis Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Tuberculosis Therapeutics Consumption by Country (2017-2022)
-
Figure United States Tuberculosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Tuberculosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Tuberculosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Tuberculosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Tuberculosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Tuberculosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Tuberculosis Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Tuberculosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Tuberculosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Tuberculosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Tuberculosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Tuberculosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Tuberculosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Isoniazid Consumption and Growth Rate (2017-2022)
-
Figure Global Rifampin Consumption and Growth Rate (2017-2022)
-
Figure Global Pyrazinamide Consumption and Growth Rate (2017-2022)
-
Figure Global Hydrazine Derivatives Consumption and Growth Rate (2017-2022)
-
Figure Global Miscellaneous Anti-Tubercular Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Ethambutol Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Individual Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Isoniazid Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rifampin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pyrazinamide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hydrazine Derivatives Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Miscellaneous Anti-Tubercular Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ethambutol Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Individual Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Tuberculosis Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Tuberculosis Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Sigma Pharmaceutical Pty (Foundation Year, Company Profile and etc.)
-
Table Sigma Pharmaceutical Pty Tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sigma Pharmaceutical Pty Tuberculosis Therapeutics Product and Service
-
Table Sanofi -Aventis (Foundation Year, Company Profile and etc.)
-
Table Sanofi -Aventis Tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi -Aventis Tuberculosis Therapeutics Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Tuberculosis Therapeutics Product and Service
-
Table Bayer Health Care (Foundation Year, Company Profile and etc.)
-
Table Bayer Health Care Tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Health Care Tuberculosis Therapeutics Product and Service
-
Table Aventis Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Aventis Pharmaceuticals Tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aventis Pharmaceuticals Tuberculosis Therapeutics Product and Service
-
Table Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table Hoffmann-La Roche Tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hoffmann-La Roche Tuberculosis Therapeutics Product and Service
-
Table Versapharma Incorporated (Foundation Year, Company Profile and etc.)
-
Table Versapharma Incorporated Tuberculosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Versapharma Incorporated Tuberculosis Therapeutics Product and Service
-
